Chirag Tilara is the Director of Quality for the Coronary business of Medtronic's Coronary and Structural Heart Disease Management business unit. Chirag has been with Medtronic Cardiovascular for 9 years and has worked in the Medical Device and Pharmaceutical Industry for over 11 years. As a Director of Quality at Medtronic, Chirag is responsible for developing and executing Quality strategy for the Coronary business unit. Specifically, he is responsible for providing Quality and Organizational leadership in product development (pre-market) quality and sustaining engineering (post-market) of global coronary products. In the pre-market area, Chirag is responsible for Quality activities in development of Medtronic's next generation of therapies for the treatment of coronary artery disease. These therapies involve coronary stents, balloon catheters, interventional devices and accessories including combination products such as Drug Eluting Stents. In the post-commercialization area, he is responsible for oversight and management of health and compliance of the coronary products globally. This responsibility includes providing manufacturing support, supporting regulatory inspections, ensuring customer satisfaction and meeting Quality metrics for the business. He completed his BE in Chemical Engineering from L.D College of Engineering, Ahmedabad, India and ME in Chemical Engineering from Widener University, Chester PA. Chirag is currently pursuing Masters in Business Administration at University of San Francisco, CA. Previous to Medtronic, Chirag worked as Quality Manager at San-Mar Laboratories in Elmsford, NY and Premier Brands of America, Mount Vernon, NY.